VOYA Investment Management
KRTX

VOYA Investment Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

VOYA Investment Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,783
Closed -$6.58M – 2912
2023
Q4 		$6.58M Sell
20,783
-394
-2% -$76.6K 0.01% 888
2023
Q3 		$3.58M Sell
21,177
-472
-2% -$88.7K ﹤0.01% 1103
2023
Q2 		$4.69M Sell
21,649
-24,039
-53% -$5.15M ﹤0.01% 1019
2023
Q1 		$8.3M Sell
45,688
-3,305
-7% -$632K 0.01% 789
2022
Q4 		$9.63M Sell
48,993
-1,215
-2% -$261K 0.01% 733
2022
Q3 		$11.3M Buy
50,208
+16,081
+47% +$3.25M 0.01% 666
2022
Q2 		$4.32M Buy
34,127
+25,429
+292% +$2.92M 0.01% 794
2022
Q1 		$1.1M Hold
8,698
– – ﹤0.01% 1421
2021
Q4 		$1.14M Buy
8,698
+58
+0.7% +$7.5K ﹤0.01% 1460
2021
Q3 		$1.06M Hold
8,640
– – ﹤0.01% 1531
2021
Q2 		$985K Buy
8,640
+1,690
+24% +$198K ﹤0.01% 1647
2021
Q1 		$836K Buy
6,950
+66
+1% +$7.48K ﹤0.01% 1710
2020
Q4 		$699K Buy
6,884
+1,530
+29% +$142K ﹤0.01% 1709
2020
Q3 		$414K Hold
5,354
– – ﹤0.01% 1775
2020
Q2 		$597K Buy
5,354
+82
+2% +$7.13K ﹤0.01% 1551
2020
Q1 		$380K Buy
+5,272
New +$451K ﹤0.01% 1794

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

VOYA Investment Management's KRTX Position: Q1 2024 in Review

VOYA Investment Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 20,783 shares — an estimated $6.58M sold.

VOYA Investment Management first reported a position in KRTX in Q1 2020 and held it in 16 quarters. The position peaked at $11.3M in Q3 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • VOYA Investment Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • VOYA Investment Management sold 20,783 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $6.58M.
  • VOYA Investment Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 16 quarters.
  • VOYA Investment Management's Karuna Therapeutics, Inc. Common Stock position peaked at $11.3M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on VOYA Investment Management's 13F filing for Q1 2024, filed 15 May 2024.